The board of directors of Dawnrays Pharmaceutical (Holdings) Ltd. announced that Mr. Chen Shaojun rendered his letter of resignation to the Company due to intention to focus on his other business and resigned from his position as an executive director of the company as well as other directorships and general manager at the subsidiary or associated company level of the Company with effect from February 16, 2022. Mr. Chen has confirmed that he has no disagreement with the Board and there are no other matters relating to his resignation that need to be brought to the attention of holders of securities of the Company or The Stock Exchange of Hong Kong Limited.
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
1.17 HKD | 0.00% | +1.74% | +11.43% |
Mar. 26 | Dawnrays Pharmaceutical Limited Proposes Final Dividend for the Year Ended 31 December 2023, Payable on 12 June 2024 | CI |
Mar. 25 | Dawnrays' 2023 Profit Falls 9% on Lower Revenue | MT |
1st Jan change | Capi. | |
---|---|---|
+11.43% | 224M | |
+25.83% | 661B | |
+27.00% | 566B | |
-6.76% | 352B | |
+20.34% | 332B | |
+3.00% | 283B | |
+13.09% | 231B | |
+5.46% | 200B | |
-9.61% | 195B | |
-6.26% | 145B |
- Stock Market
- Equities
- 2348 Stock
- News Dawnrays Pharmaceutical (Holdings) Limited
- Dawnrays Pharmaceutical Limited Announces Resignation of Chen Shaojun as Executive Director, Effective February 16, 2022